High-risk Heart surgery saves life of 68-year-old farmer at Fortis Hospital Vadapalani
Chennai, November 30, 2022: A 68-year-old farmer got a new lease of life post a challenging Redo Sutureless Aortic Valve Replacement at Fortis Hospital, Vadapalani. The farmer had earlier undergone an aortic valve repl acement surgery in 2017 as he had suffered from calcified aortic valve leading to severe aortic stenosis (Aortic Valve Stenosis is a valvular disease, which reduces or blocks blood flow from the heart to the aorta and to the rest of the body). The surgery was performed to install bioprosthetic valve to save the patient’s life. Over the period, the va lve got degenerated due to calcium deposits, which made the heart valve opening narrow leading to blocked blood flow.
In November 2022, the patient was admitted under Dr. Govini Balasubramani, Head – CTVS, Heart & Lung Tran splant Program at Fortis Hospital, Vadapalani as he experienced breathlessness. Diagnosis reports revealed that the heart valve had degenerated with severe calcific aortic re-stenosis and aortic regurgitation (a condition that occurs when your heart’s aortic valve does not close tightly). As a result, the blood pumped out of the heart’s left ven tricle leaks backward. If left untreated, a leaky valve could lead to heart failure and even death.
Giving details of the surgery, Dr. Govini said, “We evaluated different options to treat the patient and even considered TAVI (Transcatheter Aortic Valve Implantation) procedure – a minimally invasive procedure where a new valve can be ins erted inside the degenerated valve without removing the valve. However, the doctors’ team faced another challenge dur ing Transesophageal Echo. Patient’s aortic valve, which is supposed to be 21mm in normal condition, was found to be le ss than 20 mm. This is risky as the strength of aortic valve may get weak or damaged while dilating. Considering the risks factors, we decided to go ahead with Redo Sutureless Aortic Valve Replacement.”
Dr Govini elaborates further “The patient’s breastbone was separated via sternotomy to remove the degenerated valve. The native damaged valve was replaced with a 21mm bioprosthetic/sutureless valve. Sutureless valve replacement is ty pically recommended for elderly patients or patients with comorbidities as it does not require sewing the new valve into position, the surgery is less complex with quick recovery time. In most cases, placing the sutureless valve takes less than 3 minutes. It also reduces post-operative complications such as blood transfusions, renal failure, atrial fibrillation, prolong ed ventilation. Post-surgery the patient has recovered well and was discharged within 3 days.”
Mr. Venkata Phanidhar Nelluri, SBU Head at Fortis Hospitals Chennai added, “This was an incredibly challenging case considering the condition and age of the patient. However, timely assessment and treatment by our team of specia lists helped the patient get a new lease of life. We are proud of Dr. Govini Balasubramani and his team of Cardiothoracic Surgeons, ICU Specialists, Cardiac Anaesthesiologists, the Cardiologists and nurses to have helped the patient recover quickly.”
About Fortis Hospital, Vadapalani: Fortis Hospital, Vadapalani is the second facility within Chennai from the country’s fastest growing healthcare group – Fortis Healthcare and centrally located in the bustling epicentre of Arcot Road, Vada palani. The 250 bedded Quaternary care super specialty hospital hosts a 24×7 Emergency Centre with Ambulance Servi ces, Centre of Excellence in Cardiac, Gastro, Renal, Neuro, Trauma & Orthopaedics Care. We are the largest multi organ transplant centre in Chennai which includes heart, lung, liver, kidney, small bowel, and pancreas.
About Fortis Healthcare Limited
Fortis Healthcare Limited – an IHH Healthcare Berhad Company – is a leading integrated healthcare services provider in India. It is one of the largest healthcare organizations in the country with twenty-seven healthcare facilities (including projects under development), 4100 operational beds and over 419 diagnostics centres (including JVs). Fortis is present in India, United Arab Emirates (UAE) & Sri Lanka. The Company is listed on the BSE Ltd and National Stock Exchange (NSE) of India. It draws strength from its partnership with global major and parent company, IHH, to build upon its culture of world-class patient care and superlative clinical excellence. Fortis employs 23,000 people (including SRL) who share its vision of becoming the world’s most trusted healthcare network. Fortis offers a full spectrum of integrated healthcare services ranging from clinics to quaternary care facilities and a wide range of ancillary services.
